Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18564537 | PROTECTIVE VACCINE ANTIGEN AGAINST STREPTOCOCCAL INFECTION | Non-Final OA | The Regents of the University of California |
| 17620633 | BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18554423 | MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE | Non-Final OA | The Board of Trustees of the University of Illinois |
| 18278118 | BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS | Non-Final OA | UNM RAINFOREST INNOVATIONS |
| 18562157 | IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER | Non-Final OA | Evonik Operations GmbH |
| 18895960 | STRAINS, COMPOSITIONS AND METHODS OF USE | Final Rejection | L'Oreal S.A. |
| 18261568 | Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines | Non-Final OA | University of Rochester |
| 18037837 | NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 17785524 | Methods for Identifying Modulators of G Protein-Coupled Receptors | Final Rejection | University of Miami |
| 18030160 | A FACTOR H BINDING PROTEIN B (FHBB) BASED CHIMERIC VACCINE FOR THE PREVENTION AND TREATMENT OF PERIODONTAL DISEASE | Non-Final OA | VIRGINIA COMMONWEALTH UNIVERSITY |
| 18248130 | IMMUNOGENIC SCHISTOSOMA COMPOSITIONS | Final Rejection | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY |
| 18650203 | Bifidobacterium animalis in enriching organic zinc to promote growth and reproductive development | Non-Final OA | Jiangnan University |
| 18552827 | Vaccine Compositions for Trypanosomatids | Non-Final OA | Universiteit Antwerpen |
| 18042251 | ORAL CARE COMPOSITION COMPRISING A FRUCTANASE | Final Rejection | Novozymes A/S |
| 18447146 | PURIFICATION PROCESSES FOR POLYSACCHARIDES AND POLYPEPTIDE CONJUGATES THEREOF | Non-Final OA | Vaxcyte, Inc. |
| 18258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | Non-Final OA | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. |
| 18570758 | EXTRACT WITH ANTI-INFLAMMATORY EFFECT | Non-Final OA | ASDI-Austrian Drug Screening Institute GMBH |
| 18284513 | IMMUNOGENIC FUSION PROTEIN | Non-Final OA | MINERVAX APS |
| 18278251 | Methods and Compositions Using Combinations of Lactobacillus Mucosae and Soluble Dietary Fiber | Non-Final OA | Agriculture and Food Development Authority (TEAGASC) |
| 18270293 | RECOMBINANT MICROORGANISM EXPRESSING FUCOSYLTRANSFERASE, AND METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING SAME | Non-Final OA | SAMYANG CORPORATION |
| 18448685 | ANTI-MICROBIAL ANTIBODY SIGNATURES OF INFLAMMATORY BOWEL DISEASE AND USES THEREOF | Non-Final OA | Mayo Foundation for Medical Education & Research |
| 18232995 | Vector Transmitted Infectious Disease Assay | Non-Final OA | Tick Off, LLC |
| 18032350 | FERMENTED COMPOSITION | Final Rejection | MANDA FERMENTATION CO., LTD. |
| 18329816 | COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN | Non-Final OA | University of Idaho |
| 17576339 | ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT | Non-Final OA | ZIVO Bioscience, Inc. |
| 17636581 | Formulations for Prevention or Reduction of C. Difficile Infections | Non-Final OA | Sporegen Limited |
| 17801099 | PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE TREATMENT | Final Rejection | Sanofi Pasteur Inc. |
| 17793337 | Plasmid For Bacillus Expressing Fluorescent Reporter Genes | Final Rejection | Novozymes BioAg A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy